General Information

We are a life sciences company that has developed a next generation, ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Our platform enables customers to reliably detect protein biomarkers in extremely low concentrations in blood, serum and other fluids that, in many cases, are undetectable using conventional, analog immunoassay technologies.

Employees: 122
Founded: 2007
Contact Information
Address 113 Hartwell Avenue, Lexington, MA 02421, US
Phone Number (617) 301-9400
Web Address http://www.quanterix.com
View Prospectus: Quanterix
Financial Information
Market Cap $317.85mil
Revenues $23.0 mil (last 12 months)
Net Income $-31.4 mil (last 12 months)
IPO Profile
Symbol QTRX
Exchange NASDAQ
Shares (millions): 4.3
Price range $15.00 - $15.00
Est. $ Volume $64.1 mil
Manager / Joint Managers J.P. Morgan/ Leerink Partners
CO-Managers BTIG/ Evercore ISI
Expected To Trade: 12/7/2017
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change